| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000050580B1 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 09/07/2001 | WO2000046389A9 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 09/07/2001 | CA2744921A1 Hybrid expression of neisserial proteins |
| 09/07/2001 | CA2689666A1 Heterologous expression of neisserial proteins |
| 09/07/2001 | CA2401993A1 Human monoclonal antibodies against oxidized ldl receptor and pharmaceutical uses thereof |
| 09/07/2001 | CA2401965A1 Production of antibodies in transgenic plastids |
| 09/07/2001 | CA2401741A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | CA2401700A1 Manufacture and purification of cyclosporin a |
| 09/07/2001 | CA2401683A1 Design and discovery of protein based tnf-.alpha. variants for the treatment of tnf-.alpha. related disorders |
| 09/07/2001 | CA2401652A1 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | CA2401544A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2401175A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2400679A1 Human schizophrenia gene |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/07/2001 | CA2400058A1 Protein scaffolds for antibody mimics and other binding proteins |
| 09/07/2001 | CA2399847A1 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
| 09/07/2001 | CA2397502A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/06/2001 | WO2001064715A2 Memno peptides, a process for their preparation and their use |
| 09/06/2001 | US20010019716 Ability to enter mammalian cells and to survive within macrophages; vaccines to prevent infection by Mycobacterium tuberculosis, diagnostic assays |
| 09/06/2001 | DE10107360A1 Novel metalloprotease containing a thrombospondin domain (MPTS protein) is useful to treat aggrecan associated disease including rheumatoid arthritis and osteoarthritis |
| 09/05/2001 | EP1130103A2 Nucleic acid from Tetrahymena coding for a trieterpenoid-cyclase, its production and use |
| 09/05/2001 | EP1130098A2 Mammalian osteoregulins |
| 09/05/2001 | EP1130093A1 Oligonucleotide mediated nucleic acid recombination |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1130030A1 Human erythroid differentiation related factor |
| 09/05/2001 | EP1130029A1 Protein amsh and cdna thereof |
| 09/05/2001 | EP1130027A1 Memno peptides, process for preparation and use thereof |
| 09/05/2001 | EP1129718A2 Therapeutic uses of bactericidal/permeability increasing protein products |
| 09/05/2001 | EP1129207A1 Catalytic antibodies and method for producing chromanes by cyclization with said antibodies |
| 09/05/2001 | EP1129197A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 09/05/2001 | EP1129196A2 Virulence genes and proteins, and their use |
| 09/05/2001 | EP1129194A2 Interleukin-1 homolog zil1a4 |
| 09/05/2001 | EP1129193A1 Chemokine beta-7 |
| 09/05/2001 | EP1129190A1 Human tslp dna and polypeptides |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129183A2 Human glycine transporter type 2 |
| 09/05/2001 | EP1129181A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 09/05/2001 | EP1129110A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 09/05/2001 | EP1129105A1 Dna molecules encoding the melanocortin 4 receptor protein from rhesus monkey |
| 09/05/2001 | EP1129104A1 Dna molecules encoding the melanocortin 3 receptor protein from rhesus monkey |
| 09/05/2001 | EP0792160B1 Glial derived neurotrophic factor as a neuroprotective agent |
| 09/05/2001 | EP0513090B1 Hepatitis a vaccines |
| 09/05/2001 | CN1311794A Aerothricin analogs, their prepn. and use |
| 09/05/2001 | CN1311691A Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 09/05/2001 | CN1311439A Human RTN 4B protein and code sequence, and its preparation and use |
| 09/05/2001 | CN1311332A Producing erythrocyte irritable factor/granulocyte colony irritable factor fusion protein by genetic engineering method |
| 09/05/2001 | CN1311257A Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |
| 09/05/2001 | CN1311255A Process for producing recombined lymphotoxin derivative |
| 09/05/2001 | CN1070611C Hybridoma cell lines and thier monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 09/04/2001 | US6284949 A chimeric plant gene having a promoter for rna production, a dna sequence with insecticidally activity and a 3' non-translated dna sequence which causes polyadenylation of the rna; producing insect resistant plants |
| 09/04/2001 | US6284873 Complex of human kallikrein 2 (hK2) and protease inhibitor-6 (PI-6) in prostate tumor tissue and methods of using the complex |
| 09/04/2001 | US6284872 Tendon-inducing compositions |
| 09/04/2001 | US6284870 Gamma retinoic acid receptor |
| 09/04/2001 | US6284740 Osteoprotegerin |
| 09/04/2001 | US6284728 Osteoprotegerin |
| 09/04/2001 | US6284536 Modified immunoglobin molecules and methods for use thereof |
| 09/04/2001 | US6284520 Process for the production of proteins |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284512 Mutant bacillus lentus subtilisin enzyme: one or more amino acid residues replaced with cysteine; some cysteine residues modified by replacing thiol hydrogen with side chain; improved esterase to amidase selectivity |
| 09/04/2001 | US6284493 Method of synthesizing saccharide compositions |
| 09/04/2001 | US6284492 Recombinant animal viral nucleic acids |
| 09/04/2001 | US6284491 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 09/04/2001 | US6284490 Asporogenous strain of bacillus subtilis and its use as a host for the preparation of heterologous products |
| 09/04/2001 | US6284488 Protein expression system |
| 09/04/2001 | US6284485 Nucleic acids encoding osteoprotegerin |
| 09/04/2001 | US6284484 Process for the production of proteins in soluble form by modulation of an inducible promoter |
| 09/04/2001 | US6284477 Diagnostic method of use of OMP26 antigen from Haemophilus influenzae |
| 09/04/2001 | US6284458 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 09/04/2001 | US6284456 Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor |
| 09/04/2001 | US6284454 Variant of LAV viruses |
| 09/04/2001 | US6284256 Bordetella bronchiseptica vaccine |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284252 Transdominant TAT variants of the human immunodeficiency virus |
| 09/04/2001 | US6284248 Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants |
| 09/04/2001 | US6284239 Murine model for human carcinoma |
| 09/04/2001 | CA2205430C Method for making a medicament for treating secondary immunodeficiency |
| 09/04/2001 | CA2116753C Monoclonal antibodies recognizing the epidermal growth factor-receptor, cells and methods for producing them and compositions containing them |
| 08/30/2001 | WO2001062974A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | WO2001062969A2 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | WO2001062934A1 Starch branching enzyme |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062929A2 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062907A1 Antibody library |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062770A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001053474A8 Flavobacterium heparinum expression system |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001009187A3 Human monoclonal antibodies to her2/neu |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |